ABVX
Depositary ReceiptAbivax S.A.
Reported Shares
4M
Position Mix
No options reported
Reported Value
$392.1M
Portfolio Weight
10.13%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$3.9B
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
ABVX
Depositary ReceiptAbivax S.A.
Reported Shares
4M
Position Mix
No options reported
Reported Value
$392.1M
Portfolio Weight
10.13%
NBIX
Common StockNEUROCRINE BIOSCIENCES INC
Reported Shares
2.5M
Position Mix
No options reported
Reported Value
$354.6M
Portfolio Weight
9.16%
BMRN
Common StockBIOMARIN PHARMACEUTICAL INC
Reported Shares
5.5M
Position Mix
No options reported
Reported Value
$331.5M
Portfolio Weight
8.56%
ARWR
Common StockARROWHEAD PHARMACEUTICALS, INC.
Reported Shares
4.8M
Position Mix
No options reported
Reported Value
$315.1M
Portfolio Weight
8.14%
INSM
Common StockINSMED Inc
Reported Shares
2.7M
Position Mix
No options reported
Reported Value
$311.0M
Portfolio Weight
8.04%
UTHR
Common StockUNITED THERAPEUTICS Corp
Reported Shares
475K
Position Mix
No options reported
Reported Value
$257.4M
Portfolio Weight
6.65%
ASND
Common StockAscendis Pharma A/S
Reported Shares
740K
Position Mix
No options reported
Reported Value
$168.6M
Portfolio Weight
4.36%
NRIX
Common StockNurix Therapeutics, Inc.
Reported Shares
7M
Position Mix
No options reported
Reported Value
$166.6M
Portfolio Weight
4.30%
TARS
Common StockTarsus Pharmaceuticals, Inc.
Reported Shares
2M
Position Mix
No options reported
Reported Value
$159.9M
Portfolio Weight
4.13%
ELVN
Common StockEnliven Therapeutics, Inc.
Reported Shares
3.2M
Position Mix
No options reported
Reported Value
$147.8M
Portfolio Weight
3.82%
IRON
Common StockDisc Medicine, Inc.
Reported Shares
1.6M
Position Mix
No options reported
Reported Value
$107.0M
Portfolio Weight
2.77%
BCAX
Common StockBicara Therapeutics Inc.
Reported Shares
5.5M
Position Mix
No options reported
Reported Value
$102.8M
Portfolio Weight
2.66%
DYN
Common StockDyne Therapeutics, Inc.
Reported Shares
6.2M
Position Mix
No options reported
Reported Value
$99.9M
Portfolio Weight
2.58%
IMTX
Common StockImmatics N.V.
Reported Shares
11.2M
Position Mix
No options reported
Reported Value
$98.3M
Portfolio Weight
2.54%
TSHA
Common StockTaysha Gene Therapies, Inc.
Reported Shares
18M
Position Mix
No options reported
Reported Value
$87.9M
Portfolio Weight
2.27%
GLUE
Common StockMonte Rosa Therapeutics, Inc.
Reported Shares
7.1M
Position Mix
No options reported
Reported Value
$85.1M
Portfolio Weight
2.20%
GMED
Common StockGLOBUS MEDICAL INC
Reported Shares
915K
Position Mix
No options reported
Reported Value
$68.5M
Portfolio Weight
1.77%
CBIO
Common StockCRESCENT BIOPHARMA, INC.
Reported Shares
3M
Position Mix
No options reported
Reported Value
$43.8M
Portfolio Weight
1.13%
ZBH
Common StockZIMMER BIOMET HOLDINGS, INC.
Reported Shares
475K
Position Mix
No options reported
Reported Value
$42.2M
Portfolio Weight
1.09%
TVTX
Common StockTravere Therapeutics, Inc.
Reported Shares
600K
Position Mix
No options reported
Reported Value
$35.3M
Portfolio Weight
0.91%